Triple
T22692483
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Gemin4 |
E561086
|
entity |
| Predicate | encodedBy |
P14248
|
FINISHED |
| Object | GEMIN4 gene |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: GEMIN4 gene | Statement: [Gemin4, encodedBy, GEMIN4 gene]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: GEMIN4 gene Context triple: [Gemin4, encodedBy, GEMIN4 gene]
-
A.
Gemin2
Gemin2 is a core component of the SMN complex that plays a crucial role in the assembly of small nuclear ribonucleoproteins (snRNPs) essential for pre-mRNA splicing.
-
B.
Gemin6
Gemin6 is a component of the SMN (survival motor neuron) complex involved in the assembly and maturation of small nuclear ribonucleoproteins essential for pre-mRNA splicing.
-
C.
MS4A1 gene
The MS4A1 gene is a human gene that encodes the B-cell surface molecule CD20, a key target in immunotherapy for B-cell malignancies and autoimmune diseases.
-
D.
Gemin3
Gemin3 is an RNA helicase and core component of the SMN complex that plays a crucial role in the assembly and metabolism of small nuclear ribonucleoproteins (snRNPs) involved in pre-mRNA splicing.
-
E.
GNAS
GNAS is the abbreviation for the Georgian National Academy of Sciences, the leading scientific institution in Georgia that coordinates and promotes research across various disciplines.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: GEMIN4 gene Target entity description: The GEMIN4 gene encodes a core component of the SMN-GEMIN complex that is essential for small nuclear ribonucleoprotein (snRNP) assembly and pre-mRNA splicing.
-
A.
Gemin2
Gemin2 is a core component of the SMN complex that plays a crucial role in the assembly of small nuclear ribonucleoproteins (snRNPs) essential for pre-mRNA splicing.
-
B.
Gemin6
Gemin6 is a component of the SMN (survival motor neuron) complex involved in the assembly and maturation of small nuclear ribonucleoproteins essential for pre-mRNA splicing.
-
C.
MS4A1 gene
The MS4A1 gene is a human gene that encodes the B-cell surface molecule CD20, a key target in immunotherapy for B-cell malignancies and autoimmune diseases.
-
D.
Gemin3
Gemin3 is an RNA helicase and core component of the SMN complex that plays a crucial role in the assembly and metabolism of small nuclear ribonucleoproteins (snRNPs) involved in pre-mRNA splicing.
-
E.
GNAS
GNAS is the abbreviation for the Georgian National Academy of Sciences, the leading scientific institution in Georgia that coordinates and promotes research across various disciplines.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e2454d71b48190a1f80af9f82b6fcf |
completed | April 17, 2026, 2:35 p.m. |
| NER | Named-entity recognition | batch_69f1789ba0148190891781d05ec64f3c |
completed | April 29, 2026, 3:18 a.m. |
Created at: April 17, 2026, 3:13 p.m.